One of the biggest pharmaceutical firms in the world has unveiled a new £79m vaccine production facility in France.
Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group, said it launched the facility in Val de Reuil, in north-west France, in response to soaring worldwide demand.
The move is part of a series of £475m investments undertaken by Sanofi Pasteur in France between 2005 and 2008.
President and Chief Executive Officer of Sanofi Pasteur, Wayne Pisano, said: “Sanofi Pasteur’s commitment to global health is exemplified by significant investments in vaccine production infrastructures. These efforts are aimed at meeting a world demand for vaccines expected to double by 2016.
“The new facility will provide high-end production work environment for dedicated people who produce vaccines for the world.”
The highly-automated facility can produce vaccines against 20 diseases and is designed to be able to switch to the production of pandemic influenza vaccines in the event of a human pandemic outbreak.
“Sanofi Pasteur Val de Reuil site is a hub for global health with over two million doses of vaccines shipped worldwide each day. The new facility will further enable Sanofi Pasteur to fulfil its commitment of providing highest quality vaccines to protect people from infectious diseases wherever they live,” added Pisano.
Copyright © PA Business 2008